Drug development allometric scaling

E. Ette, P. Williams, J. Lane, Y. K. Kim, and E. V. Capparelli, The determination of population pharmacokinetic model appropriateness. / Clin Pharamcol 43 2-15 (2003). V. F. Cosson, E. Fuseau, C. Efthymiopouios, and A. Bye, Mixed effect modeling of sumatriptan pharmacokinetics during drug development. I. Interspecies allometric scaling. / Pharmacokinet Biopharm 25 149-167 (1997). 

V. F. Cosson, E. Fuseau, C. Efthymiopoulos, and A. Bye, Mixed effect modeling of sumatriptan pharmacokinetics during drug development. I Interspecies allometric scaling. J Pharmacokinet Biopharm 25 149-167 (1997). 

---